Xeljanz_Xr - Drug Details
๐Ÿ“Š Estimates Xeljanz_Xr Dialyzability By Different_Modalities

Xeljanz_Xr

Complete Drug Information

Drug Name
Xeljanz_Xr
Trade Names
Xeljanz, Neojanz, Jaquinus, Tofacinix
Pregnancy Category
AU: D
Bioavailability
74%
Routes of Administration
Oral
Protein Binding
40%%
Metabolism
Liver (via CYP3A4 and CYP2C19)
Elimination
3 hours
Excretion
Urine
Formula
C16H20N6O
Molar Mass
312.377
Drug Class
Janus kinase (JAK) inhibitor
Volume of Distribution
C16H20N6O

๐Ÿคฐ Pregnancy Category Information

Category: AU: D

Drugs which have caused, are suspected to have caused, or may be expected to cause an increased incidence of human fetal malformations or irreversible damage. These drugs may also have adverse pharmacological effects.